FDA Investigator Neil J Bonzagni, PhD MPH
Neil J Bonzagni, PhD MPH has conducted inspections on 65 sites in 2 countries as of 14 Aug 2019. See below for a list of the FDA enforcement documents resulting from those inspections.
Investigator Details
Number of Inspected Sites:
65
Last Inspection Date:
14 Aug 2019
Investigator Role:
FDA Investigator
Redica ID:
Countries of Inspections:
United States of America,
India
FDA Investigators that have inspected at least one site in common with Neil J Bonzagni, PhD MPH:
Abby E Pelletier,
Adena S Yau,
Alice S Tsao,
Althea A Williams,
Amatul H Marium,
Amber D Brodas,
Amy Kim,
Amy Wyan Mai,
Andrew F Cohen,
Andrew J Garufi,
Ann L Demarco,
Arduino Frankovic,
Arsen Karapetyan,
Arthur G Hurst,
Ashley Polizzotto,
Bijoy Panicker,
Brandy N Lepage,
Carrie E Jolly,
Charanjeet Jassal,
Charisse K Green,
Christian Parra,
Christine M Rivera,
Christopher S Fields,
Coleburn E Vielehr,
Ct Viswanathan, PhD,
David R Delucia,
Dean R Rugnetta,
Debra I Love,
Demitria J Xiradakis,
Dipesh K Shah,
Dongping Dai, PhD,
Douglas G Ng,
Dr. Barbara D Paul, PhD,
Dr. Robert C Horan, MD,
Edmund F Mrak, Jr,
Eileen A Liu,
Eric Rothschild,
Erica B Brush,
Erica B Raphael,
Felix Maldonado,
Frank Verni,
Gam S Zamil,
Ganesh N Joshi,
Gary J Lehr,
Gary T Greco,
Guerlain Ulysse,
Ilana Zigelman,
Iram R Hassan, PhD,
Irina Gaberman,
Isaac N Baah,
James A Liubicich,
James M Mason,
Jane C Chen,
Jason D Tenney,
Jay T Wong,
Jennifer L Huntington,
Jessica M Monteiro,
Jogy George,
José E Meléndez,
Jose Ohernandez Guzman,
Jose V Obando,
Joseph Duca,
Joseph Maselli,
Joy P Matthias,
Joyce A Williams,
Juan Rjimenez Garcia,
Jung K Kim,
Junho Pak,
Justin A Boyd,
Karen L Kosar,
Karishma G Gopaul,
Karl Auguste,
Kejun Cheng,
Kenneth H Williams,
Kerry D Noto,
Kevin A Gonzalez,
Kevin P Foley,
Khadija A Auguste,
Kim Lthomas Cruse,
Kimberley A Ricketts,
Kimberly A Coward,
Kimberly Y Smithson,
Kwong P Lee,
Lata C Mathew, PhD,
Lawrence W Farina,
Lucila B Nwatu,
Manhar R Patel,
Marcellinus D Dordunoo,
Margaret M Sands,
Matthew A Spataro,
Matthew B Casale,
Melissa B Libby,
Mercedes G Castillo,
Meredith P Soehl, Investigator,
Michael A Charles,
Michael R Dominick,
Mindy M Chou,
Miral B Patel,
Narong Chamkasem, PhD,
Nazmul Hassan,
Nerizza B Guerin,
Nicholas J Morici,
Parul M Patel,
Patrick C Klotzbuecher,
Paul M Gelfand,
Paul Mouris,
Perez,
Peter Abel,
Peter Caparelli,
Peter M Trunk,
Peter R Caparelli,
Peter S Diak,
Philip F Istafanos, DMV, MS,
Pratik S Upadhyay, DDC,
Rachael A Moliver,
Raihan A Chowdhury,
Randolph Campos Santiago,
Raymond M Lam,
Richard Ferfoglia,
Rina Bhikha,
Rita K Kabaso,
Rita K Vick,
Robert C Howard,
Robert C Steyert,
Robert E Moncayo,
Rochelle K Kimmel,
Ronald Ifraimov,
Rose Xu,
Rupa Pradhan,
Samina S Khan,
Samuel A Francis,
Samuel T Walker,
Sangeeta M Khurana, PhD,
Sangeeta M Rataul,
Sarah A Meehan,
Sarah A Wangseng,
Sarah K Graham,
Satheesh Thomas,
Sayyem H Akbar,
Shantel S Tobias,
Shreya Shah,
Sonia E Ortiz,
Sony Mathews,
Sou Chan Chang,
Sripal R Mada, PhD,
Stephanie T Durso,
Stephen D Brown,
Steven M Weinman,
Steven P Donald,
Sunita Vij,
Susan M Joseph,
Suwaskie S Smith,
Syeda N Mahazabin,
Tanya R Syffrard,
Tara K Carmody,
Tara K Normandin,
Terry Bridgewater,
Thomas J Arista,
Thomas J Mooney,
Thomas P Hansen,
Tonia F Bernard,
Torrance J Slayton,
Tracy M Portelli,
Uduak M Inokon,
Unnee Ranjan,
Valerie A Potopsingh,
Valerie C Reed,
Victoria Spivak,
Vilmary Negron Rodriguez,
Vivin George,
Wayne S Fortenberry,
William J Leonard,
Winston R Alejo,
Xiaokuang Lai, PhD,
Xikui Chen (nmi), PhD,
Yasamin Ameri,
Yumi J Hiramine,
Yuyan Liang,
Yvesna C Blaise
Neil J Bonzagni, PhD MPH's Documents
| Publish Date | Document Type | Title |
|---|---|---|
| February, 2011 | FDA 483 | Fougera Pharmaceuticals Inc. - Form 483, 2011-02-09 |
| January, 2010 | FDA 483 | LNK International, Inc. - Form 483, 2010-01-14 |
| January, 2012 | FDA 483 | InvaGen Pharmaceuticals, Inc - Form 483, 2012-01-06 |
| April, 2012 | FDA 483 | Forest Research Institute Inc - Form 483, 2012-04-02 |
| September, 2011 | FDA 483 | ScieGen Pharmaceuticals INC - Form 483, 2011-09-16 |
| April, 2012 | EIR | Forest Research Institute Inc - EIR, 2012-04-02 |
| June, 2011 | FDA 483 | Cosco Enterprises, Inc - Form 483, 2011-06-28 |
| February, 2012 | EIR | Forest Research Institute - EIR, 2012-02-22 |
| February, 2012 | FDA 483 | Forest Research Institute - Form 483, 2012-02-22 |
Experience Redica Systems’ NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more